dronabinol has been researched along with Experimental Pneumococcal Meningitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, R; Engelhard, D; Shohami, E; Trembovler, V | 1 |
1 other study(ies) available for dronabinol and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Ceftriaxone; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Male; Meningitis, Pneumococcal; Neuroprotective Agents; Rats; Tumor Necrosis Factor-alpha | 1996 |